BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26417085)

  • 1. Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry.
    Luo H; Hernandez R; Hong H; Graves SA; Yang Y; England CG; Theuer CP; Nickles RJ; Cai W
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12806-11. PubMed ID: 26417085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
    Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
    Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.
    Luo H; England CG; Shi S; Graves SA; Hernandez R; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
    Clin Cancer Res; 2016 Aug; 22(15):3821-30. PubMed ID: 27026197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
    Shi S; Orbay H; Yang Y; Graves SA; Nayak TR; Hong H; Hernandez R; Luo H; Goel S; Theuer CP; Nickles RJ; Cai W
    J Nucl Med; 2015 Jun; 56(6):927-32. PubMed ID: 25883125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.
    Mendler CT; Friedrich L; Laitinen I; Schlapschy M; Schwaiger M; Wester HJ; Skerra A
    MAbs; 2015; 7(1):96-109. PubMed ID: 25484039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.
    Zhang Y; Hong H; Orbay H; Valdovinos HF; Nayak TR; Theuer CP; Barnhart TE; Cai W
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):759-67. PubMed ID: 23344138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment.
    Chakravarty R; Goel S; Valdovinos HF; Hernandez R; Hong H; Nickles RJ; Cai W
    Bioconjug Chem; 2014 Dec; 25(12):2197-204. PubMed ID: 25389697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
    Cardillo TM; Karacay H; Goldenberg DM; Yeldell D; Chang CH; Modrak DE; Sharkey RM; Gold DV
    Clin Cancer Res; 2004 May; 10(10):3552-61. PubMed ID: 15161715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment.
    Shi S; Hong H; Orbay H; Graves SA; Yang Y; Ohman JD; Liu B; Nickles RJ; Wong HC; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1295-303. PubMed ID: 25801992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.
    Ma T; Sun X; Cui L; Gao L; Wu Y; Liu H; Zhu Z; Wang F; Liu Z
    J Nucl Med; 2014 Jun; 55(6):1002-7. PubMed ID: 24732154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA-targeted bispecific Fab conjugates that engage T cells.
    Patterson JT; Isaacson J; Kerwin L; Atassi G; Duggal R; Bresson D; Zhu T; Zhou H; Fu Y; Kaufmann GF
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5490-5495. PubMed ID: 29126850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
    Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
    Schuhmacher J; Kaul S; Klivényi G; Junkermann H; Magener A; Henze M; Doll J; Haberkorn U; Amelung F; Bastert G
    Cancer Res; 2001 May; 61(9):3712-7. PubMed ID: 11325843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
    Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
    Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.